As a company with a long legacy of research in vaccines and infectious diseases, we’ve been committed to advancing an effective response to COVID-19 since it was first discovered.
Since their development, antibiotics have transformed health care and saved countless lives globally. But rising levels of antimicrobial resistance (AMR) make current antibiotics less effective.
